Organon & Co | OGN - Market Capitalization

Stock Price
6.32
Daily Change
-0.03 -0.47%
Monthly
-13.19%
Yearly
-59.54%
Q1 Forecast
6.16

Organon & Co reported $1.62B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.57B 967M Sep/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Glaxosmithkline GBP 86.88B 7.29B Sep/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Laboratorios Farma EUR 3.68B 430.05M Jan/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 38.41M 24.12M Mar/2026
Merck USD 261.26B 51.62B Dec/2025
Neuren Pharmaceuticals AUD 1.71B 645.78M Mar/2026
Novartis USD 246.07B 11.81B Sep/2025
Organigram Holdings CAD 378.8M 132.2M Sep/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Ovoca Bio EUR 7.54M 4.28M Jun/2022
Pharma Mar EUR 1.41B 63.87M Mar/2026
Qiagen NV USD 9.9B 207.4M Dec/2025
Sartorius EUR 16.41B 2.95B Dec/2025
Sino Biopharmaceutical CNY 114.44B 24.38B Mar/2026
Zealand Pharma A/S 33.35B 0 Feb/2026